Page last updated: 2024-11-02

pantoprazole and Hypokalemia

pantoprazole has been researched along with Hypokalemia in 2 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Hypokalemia: Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fatuzzo, P1
Portale, G1
Scollo, V1
Zanoli, L1
Granata, A1
Mojadidi, MK1
Hovnanians, N1
Kaufmann, MR1
Hill, JA1

Other Studies

2 other studies available for pantoprazole and Hypokalemia

ArticleYear
Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism.
    Journal of nephrology, 2017, Volume: 30, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Biomarkers; Cerebellar Diseases; Dietary Supplements;

2017
An Unusual Presentation of QT Prolongation.
    Texas Heart Institute journal, 2016, Volume: 43, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Action Potentials; Anti-Infective Agents; Arrhythmias, Card

2016